ReviewSeminars in interventional radiology2025
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes.
Review in Seminars in interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive condition characterized by persistent thromboembolic disease in the pulmonary arteries, leading to increased pulmonary vascular resistance and right heart failure. Medical therapy offers symptomatic relief but is not curative. Pulmonary thromboendarterectomy (PTE) remains the gold standard treatment; however, patients are often ineligible for surgery due to unfavorable anatomy, comorbidities, or preferences. Balloon pulmonary angioplasty (BPA) has emerged as a minimally invasive alternative, particularly for patients with inoperable CTEPH or post-PTE patients who remain symptomatic. Balloon catheters are used to dilate stenotic pulmonary arteries and to disrupt intraluminal webs and synechia, improving hemodynamics and leading to better quality of life. Careful patient selection for BPA is crucial, requiring a multidisciplinary approach to identify suitable candidates. Although BPA has demonstrated favorable outcomes, challenges remain in optimizing procedural techniques, reducing complication rates, and establishing standardized treatment protocols. This work aims to review BPA and its role in treating CTEPH, from patient selection to expected outcomes, as well as potential areas of future research, which includes the need for increased awareness and accessibility to specialized CTEPH centers, advancements in imaging technology, procedural standardization, and investigation of combination therapies to further support BPA efficacy and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.